The closing price of Day One Biopharmaceuticals Inc. (NASDAQ: DAWN) was $12.96 for the day, down -2.34% from the previous closing price of $13.27. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 865659 shares were traded. DAWN stock price reached its highest trading level at $13.91 during the session, while it also had its lowest trading level at $12.90.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Our analysis of DAWN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.10 and its Current Ratio is at 14.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 when Bender Jeremy sold 3,104 shares for $13.12 per share. The transaction valued at 40,732 led to the insider holds 1,179,484 shares of the business.
York Charles N II sold 955 shares of DAWN for $12,532 on May 16. The COO, CFO and Secretary now owns 264,798 shares after completing the transaction at $13.12 per share. On May 16, another insider, Blackman Samuel C., who serves as the Chief Medical Officer of the company, sold 692 shares for $13.12 each. As a result, the insider received 9,081 and left with 1,235,592 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAWN now has a Market Capitalization of 1.06B and an Enterprise Value of 723.35M.
Stock Price History:
Over the past 52 weeks, DAWN has reached a high of $28.35, while it has fallen to a 52-week low of $5.44. The 50-Day Moving Average of the stock is 13.92, while the 200-Day Moving Average is calculated to be 19.33.
DAWN traded an average of 828.80K shares per day over the past three months and 778.45k shares per day over the past ten days. A total of 71.97M shares are outstanding, with a floating share count of 51.85M. Insiders hold about 14.90% of the company’s shares, while institutions hold 82.90% stake in the company. Shares short for DAWN as of Apr 27, 2023 were 9.12M with a Short Ratio of 9.12M, compared to 7.41M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 12.40% and a Short% of Float of 22.24%.
The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$0.62 for the current quarter, with a high estimate of -$0.57 and a low estimate of -$0.66, while EPS last year was -$0.6. The consensus estimate for the next quarter is -$0.62, with high estimates of -$0.5 and low estimates of -$0.7.
Analysts are recommending an EPS of between -$2.05 and -$2.75 for the fiscal current year, implying an average EPS of -$2.48. EPS for the following year is -$2.05, with 10 analysts recommending between $0.65 and -$3.18.
Based on 10 analysts’ estimates, the company’s revenue will be $63.37M in the next fiscal year. The high estimate is $255M and the low estimate is $6.8M. The average revenue growth estimate for next year is up 14,302.30% from the average revenue estimate for this year.